These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6412992)

  • 1. [Effects of 3 varieties of antisickling substances measured by ektacytometry as a function of oxygen pressure].
    Feo CJ; Johnson RM; Nossal M
    C R Seances Acad Sci III; 1983; 296(19):911-6. PubMed ID: 6412992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisickling effects of membrane-interacting compounds.
    Ohnishi ST
    Blood Cells; 1982; 8(2):337-43. PubMed ID: 6130805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mechanism of action of two anti-sickling agents: sodium cyanate and glyceraldehyde.
    Manning JM; Acharya AS
    Am J Pediatr Hematol Oncol; 1984; 6(1):51-4. PubMed ID: 6711764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and testing of potential antisickling agents. 6. Rheologic studies with active phenoxy and benzyloxy acids.
    Patwa DC; Abraham DJ; Hung TC
    Blood Cells; 1987; 12(3):589-601. PubMed ID: 3651614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of covalent antisickling compounds by PO2 scan ektacytometry.
    Johnson RM; Féo CJ; Nossal M; Dobo I
    Blood; 1985 Aug; 66(2):432-8. PubMed ID: 4016278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for the potent antisickling effect of a novel class of five-membered heterocyclic aldehydic compounds.
    Safo MK; Abdulmalik O; Danso-Danquah R; Burnett JC; Nokuri S; Joshi GS; Musayev FN; Asakura T; Abraham DJ
    J Med Chem; 2004 Sep; 47(19):4665-76. PubMed ID: 15341482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of erythrocyte sickling by thiol reagents.
    Garel MC; Domenget C; Galacteros F; Martin-Caburi J; Beuzard Y
    Mol Pharmacol; 1984 Nov; 26(3):559-65. PubMed ID: 6493211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of sickling.
    Mentzer WC
    Am J Pediatr Hematol Oncol; 1982; 4(3):320-7. PubMed ID: 7149171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheological assessment of antisickling effects of pyridoxine and pyridoxal.
    Kuranstin-Mills J; Lessin LS
    Blood Cells; 1982; 8(2):315-28. PubMed ID: 7159755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of pH on the rheologic and antisickling effects of dimethyl adipimidate.
    Pennathur-Das R; Lande WM; Mentzer WC; Mohandas N; Preisler H; Kleman KM; Heath RH; Lubin BH
    J Lab Clin Med; 1984 Nov; 104(5):718-29. PubMed ID: 6491469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisickling agents as inhibitors of glucose transport in human erythrocytes.
    Lacko L; Wittke B
    Arzneimittelforschung; 1982; 32(6):684-5. PubMed ID: 7202373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro study of ticlopidine, as a model of antisickling action of platelet antiaggregant.
    Sablayrolles M; Wajcman H; Castaigne JP; Labie D
    Haematologia (Budap); 1984; 17(2):199-207. PubMed ID: 6534828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Covalent inhibitors of the gelation of sickle cell hemoglobin and their effects on function.
    Manning JM
    Adv Enzymol Relat Areas Mol Biol; 1991; 64():55-91. PubMed ID: 2053469
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cetiedil on monovalent cation permeability in the erythrocyte: an explanation for the efficacy of cetiedil in the treatment of sickle cell anemia.
    Berkowitz LR; Orringer EP
    Blood Cells; 1982; 8(2):283-8. PubMed ID: 7159752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pyridyl derivatives of benzaldehyde as potential antisickling agents.
    Nnamani IN; Joshi GS; Danso-Danquah R; Abdulmalik O; Asakura T; Abraham DJ; Safo MK
    Chem Biodivers; 2008 Sep; 5(9):1762-9. PubMed ID: 18816529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viscosity and filtrability measurements of sickle-cell suspensions in the development of anti-sickling drugs.
    Ohnishi ST
    Blood Cells; 1982; 8(1):79-87. PubMed ID: 7115980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RSR13, a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs.
    Pagel PS; Hettrick DA; Montgomery MW; Kersten JR; Steffen RP; Warltier DC
    J Pharmacol Exp Ther; 1998 Apr; 285(1):1-8. PubMed ID: 9535987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study of erythrocyte deformability using visco-diffractometry (ektacytometry) in hereditary hemolytic anemias].
    Herrera A; Feo CJ
    Nouv Rev Fr Hematol (1978); 1984; 26(3):169-77. PubMed ID: 6739286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylisocyanate as an antisickling agent and its reaction with hemoglobin S.
    Lee CK
    J Biol Chem; 1976 Oct; 251(20):6226-31. PubMed ID: 977566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a pharmacologically-induced shift of hemoglobin-oxygen dissociation on myocardial energetics during ischemia in patients with coronary artery disease.
    Najjar SS; Bottomley PA; Schulman SP; Waldron MM; Steffen RP; Gerstenblith G; Weiss RG
    J Cardiovasc Magn Reson; 2005; 7(4):657-66. PubMed ID: 16136855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.